Park Place Capital Corp Spring Works Therapeutics, Inc. Transaction History
Park Place Capital Corp
- $291 Million
- Q2 2024
A detailed history of Park Place Capital Corp transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Park Place Capital Corp holds 28 shares of SWTX stock, worth $913. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28
Previous 28
-0.0%
Holding current value
$913
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding SWTX
# of Institutions
220Shares Held
66.8MCall Options Held
64.7KPut Options Held
150K-
Vanguard Group Inc Valley Forge, PA6.54MShares$214 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.62MShares$183 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.7MShares$121 Million4.57% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.6MShares$118 Million0.02% of portfolio
-
Boxer Capital, LLC San Diego, CA3.42MShares$112 Million7.16% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $2.04B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...